AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 114 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $247,000 | +26.0% | 12,800 | 0.0% | 0.00% | +100.0% |
| Q2 2018 | $196,000 | -18.3% | 12,800 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $240,000 | -37.8% | 12,800 | -46.4% | 0.00% | -33.3% |
| Q2 2016 | $386,000 | +32.6% | 23,900 | -1.3% | 0.00% | +50.0% |
| Q1 2016 | $291,000 | -15.7% | 24,225 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $345,000 | +271.0% | 24,225 | +207.4% | 0.00% | +100.0% |
| Q3 2015 | $93,000 | -33.1% | 7,880 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $139,000 | – | 7,880 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alambic Investment Management, L.P. | 29,423 | $583,000 | 0.44% |
| Matarin Capital Management, LLC | 223,184 | $4,426,000 | 0.34% |
| Summit Global Investments | 42,725 | $847,000 | 0.10% |
| FEDERATED HERMES, INC. | 1,747,921 | $34,661,000 | 0.08% |
| ROTHSCHILD & CO ASSET MANAGEMENT US INC. | 347,307 | $6,887,000 | 0.08% |
| MARSHALL WACE, LLP | 413,293 | $8,196,000 | 0.06% |
| BOSTON ADVISORS LLC | 42,365 | $840,000 | 0.04% |
| MARTINGALE ASSET MANAGEMENT L P | 214,444 | $4,254,000 | 0.04% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 177,321 | $3,516,000 | 0.04% |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 231,041 | $4,582,000 | 0.04% |